what is the difference between glp 1 2 and 3 GLP-1, GLP-2, GLP-3 Retatrutide vs Semaglutide and Tirzepatide:

Whether you achieve a 20% weight reduction through bariatric surgery, strict dieting, or an AOM, the composition of that weight loss remains remarkably consistent

Although previous studies showed a lack of therapeutic benefit for GIP agonists, current studies show that the glucose lowering and weight loss effects of tirzepatide are at least as effective as GLP-1 RAs with a similar adverse effect profile

Key points The incretin hormone glucagon-like peptide 1 (GLP1) promotes satiety and potentiates insulin release and suppression of glucagon release in response to the ingestion of nutrients

GLP-1 RAs shouldnt be taken by anyone with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome

Market your ability to help navigate the options not just offer a single product

Shared decision-making between patients and clinicians should weigh cardiovascular benefits against cost, adverse effects, and individual treatment goals